BioConnect has unveiled its new Arc Series of biometric authentication devices, designed specifically for enterprise and data center environments. The series includes three devices: Arc Vision for facial authentication, Arc Touch for fingerprint authentication, and Arc Rex, a multi-modal facial authentication device scheduled for release in September 2025. This launch builds upon BioConnect’s recent expansion of its Trust Platform, which added consent tracking capabilities in 2022.
The Arc Vision device implements AI-powered facial authentication technology, while Arc Touch offers fingerprint authentication capabilities. Both devices are built to meet IP67 and IK09 certification standards for durability and feature multi-card support for high-traffic areas. The upcoming Arc Rex will combine multi-modal facial authentication with multi-factor authentication capabilities in a compact, ruggedized design, following similar approaches to recent innovations in multi-modal authentication.
All devices in the Arc Series integrate with the BioConnect Trust Platform and incorporate automatic biometric enrollment functionality, which utilizes existing profile images to eliminate manual enrollment processes. This automated enrollment approach addresses a key challenge in enterprise biometric deployment, where manual enrollment has traditionally been a significant bottleneck. The series maintains compliance with global privacy standards, including GDPR and ISO 27001, and is compatible with major access control systems. BioConnect’s commitment to data security is evidenced by their adherence to the same ISO standards that have become increasingly crucial in enterprise identity management.
Rob Douglas, BioConnect’s Founder and CEO, states, “Today marks a pivotal moment for BioConnect and the access control industry. The Arc Series is the culmination of years of innovation, designed to provide organizations with the tools they need to safeguard their people, data, and assets.”
The Arc Series devices feature AI-powered biometric technology for authentication, privacy-first design principles, and durability certifications. The system’s integration capabilities allow for installation with minimal disruption to existing access control infrastructure, building on BioConnect’s experience from their recent acquisitions and platform expansions in the security sector.
Sources: BioConnect
–
January 8, 2025 – by Ji-seo Kim
Follow Us